The combination of methamphetamine and of the HIV protein, Tat, induces death of the human neuroblastoma cell line, SH-SY5Y

Synapse

Volumn 62, Issue 7, 2008, Pages 551-552

  Ning, Sheng Cai ^a   Cadet, Jean Lud ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

HIV 1 Tat protein; Methamphetamine; SH SY5Y

Indexed keywords

METHAMPHETAMINE; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL ACTIVITY; CELL DEATH; CONTROLLED STUDY; EXPOSURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MOLECULAR DYNAMICS; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

AIDS DEMENTIA COMPLEX; AMPHETAMINE-RELATED DISORDERS; BRAIN; CELL DEATH; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG SYNERGISM; HUMANS; METHAMPHETAMINE; NERVE DEGENERATION; NEUROBLASTOMA; NEURONS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TIME FACTORS;

EID: 44849144144     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20512     Document Type: Article

References (8)

1. Cadet JL, Krasnova I. 2007. Interactions of HIV and methamphetamine: Cellular and molecular mechanisms of toxicity potentiation. Neurotox Res 12:1-24.
2. Chana G, Everall IP, Crews L, Langford D, Adame A, Grant I, Cherner M, Lazzaretto D, Heaton R, Ellis R, Masliah E. 2006. Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology 67:1486-1489.
3. Kapadia F, Vlahov D, Donahoe RM, Friedland G. 2005. The role of substance abuse in HIV disease progression: Reconciling differences from laboratory and epidemiologic investigations. Clin Infect Dis 41:1027-1034.
4. Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E. 2003. Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr 34:467-474.
5. Langford D, Grigorian A, Hurford R, Adame A, Crews L, Masliah E. 2004. The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. J Neurovirol 10:327-337.
6. Maragos WF, Young KL, Turchan JT, Guseva M, Pauly JR, Nath A, Cass WA. 2002. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J Neurochem 83:955-963.
7. Taylor MJ, Schweinsburg BC, Alhassoon OM, Gongvatana A, Brown GG, Young-Casey C, Letendre SL, Grant I. 2007. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy. J Neurovirol 13:150-159.
8. Theodore S, Cass WA, Maragos WF. 2006. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Neuroscience 137:925-935.